论文部分内容阅读
目的:评价临床药师在缺血性脑卒中患者延续服务中所起的作用。方法:146例缺血性脑卒中患者配对分组。观察组执行延续服务方案,对照组出院后1个月实施电话随访。比较两组患者出院后3,6,12个月的服药依从性(Morisky量表)、收缩压(SBP)、舒张压(DBP)、糖化血红蛋白(Hb A1c)、血清总胆固醇(TC)、低密度脂蛋白(LDL-C)、健康行为(HPLPⅡ量表)和脑卒中复发率等指标的差异。结果:观察组在出院后3,6,12个月的服药依从性、SBP、DBP、Hb A1c、TC、LDL-C、健康行为等指标比较差异无统计学意义(P>0.05),而对照组在出院后3,6,12个月上述指标比较差异有统计学意义(P<0.05或P<0.01)。出院后3个月两组患者各项指标比较,差异无统计学意义(P>0.05);而出院后6,12个月两组各项指标比较,差异有统计学意义(P<0.05)。结论:临床药师在缺血性脑卒中患者延续服务中可提高患者药物治疗的依从性和健康行为,更好的控制血压、血糖和血脂水平,降低复发率,值得在临床实践工作中推荐。
PURPOSE: To evaluate the role of clinical pharmacists in the continuation of services in patients with ischemic stroke. Methods: A total of 146 patients with ischemic stroke were grouped. The observation group to implement the continuation of service programs, the control group 1 month after the implementation of telephone follow-up. The medication compliance (Morisky scale), SBP, DBP, Hb A1c, serum total cholesterol (TC) at 3, 6 and 12 months after discharge were compared between the two groups. Density lipoprotein (LDL-C), health behavior (HPLP Ⅱ scale) and the recurrence rate of stroke and other indicators of difference. Results: The medication compliance, SBP, DBP, Hb A1c, TC, LDL-C and health behaviors in the observation group were not significantly different at 3, 6 and 12 months after discharge (P> 0.05) There were significant differences in the above indexes between 3, 6 and 12 months after discharge (P <0.05 or P <0.01). There was no significant difference between the two groups at 3 months after discharge (P> 0.05). However, there was significant difference between the two groups after 6 and 12 months of discharge (P <0.05). Conclusion: The clinical pharmacist can improve the drug treatment compliance and health behaviors of patients with ischemic stroke, and better control blood pressure, blood glucose and blood lipid levels and reduce the recurrence rate, which is worth recommending in clinical practice.